Picture of Biostem Technologies logo

BSEM Biostem Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Biostem Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2015
December 31st
R2016
December 31st
2017
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PRESSARSARSARSARS
Standards:
USG
USG
U
USG
U
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.38-3.2-4.84-2.37-1.41
Depreciation
Amortisation
Non-Cash Items1.61.652.330.628-0.142
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.378-0.3150.4210.9160.642
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.354-1.7-1.89-0.582-0.625
Capital Expenditures-1.8-0.623-0.156
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.061
Sale of Fixed Assets
Cash from Investing Activities-1.8-0.623-0.1560.061
Financing Cash Flow Items0.0330.068
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.512.051.920.5420.804
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.361-0.285-0.128-0.040.24

Or unlock with your email

Or unlock with your email